IP Verse

Sustained Release Formulations Using Non-Aqueous Carriers - EP2341905

The patent EP2341905 was granted to Amylin Pharmaceuticals on Sep 13, 2023. The application was originally filed on Sep 4, 2009 under application number EP09812292A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP2341905

AMYLIN PHARMACEUTICALS
Application Number
EP09812292A
Filing Date
Sep 4, 2009
Status
Patent Maintained As Amended
Aug 11, 2023
Grant Date
Sep 13, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

INSTONEJan 28, 2021ADMISSIBLE

Patent Citations (23) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS5424286
DESCRIPTIONUS6479065
DESCRIPTIONUS6495164
DESCRIPTIONUS6667061
DESCRIPTIONUS6824822
DESCRIPTIONUS6858576
DESCRIPTIONUS6872700
DESCRIPTIONUS6956025
DESCRIPTIONUS7157555
DESCRIPTIONUS7220721
DESCRIPTIONUS7223440
DESCRIPTIONUS7223725
DESCRIPTIONUS7456254
DESCRIPTIONUS7563871
DESCRIPTIONWO2007022518
DESCRIPTIONWO2007139941
INTERNATIONAL-SEARCH-REPORTUS2004224030
INTERNATIONAL-SEARCH-REPORTUS2008146490
OPPOSITIONEP2011452
OPPOSITIONWO2005110425
OPPOSITIONWO2007024700
SEARCHUS2004224030
SEARCHWO2005102293

Non-Patent Literature (NPL) Citations (9) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- Anonymous, "Amylin Product Pipeline - Exenatide Lar (Long Acting Release)", Amylin Pharmaceuticlas, (20040606), page 1, XP055979545-
OPPOSITION- Anonymous, "Byetta exenatide injection 250mcg/ml, 1.2 ml", Pen User Manual, (20060000), pages 1 - 4, XP055979581-
OPPOSITION- Anonymous, "Product Information Miglyol 810, 812, 818, 829, 840, neutral oils for pharmaceuticals and cosmetics", Sasol reaching new frontiers, (20040900), pages 1 - 7, XP055979556-
OPPOSITION- Anonymous, "Study demonstrated once-weekly exenatide LAR improved glucose control in patients with type 2 diabetes", Lilly press release, (20060610), pages 1 - 4, XP055675770-
OPPOSITION- D J DRUCKER et al., "Exenatide once weekly vs twice daily for the treatment of type 2 diabetes: a randomised, open label, non-inferiority study", The Lancet, (20080908), vol. 372, doi:10.1016/S0140-6736(08)61206-4, pages 1240 - 50, XP025480737
OPPOSITION- R.A JAIN et al., "Controlled release of drugs from injectable in situ formed biodegradable PLGA microspheres: effect of various formulation variables", European Journal of Pharmaceutics and Biopharmaceutics, (20000000), vol. 50, doi:10.1016/S0939-6411(00)00062-X, pages 257 - 262, XP004257199
OPPOSITION- R.A JAIN et al., "Controlled delivery of drugs from a novel injectable in situ formed biodegradable PLGA microsphere system", J. Microencapsulation, (20000000), vol. 17, no. 3, doi:10.1080/026520400288319, XP000912452
OPPOSITION- RAJEEV JAIN, "Controlled drug delivery from a novel injectable in situ formed biodegradable PLGA microsphere system", PhD Thesis, University of Rhode Island, (19980000), pages 1 - 208, XP000912452
SEARCH- JAIN R A ET AL, "Controlled release of drugs from injectable in situ formed biodegradable PLGA microspheres: effect of various formulation variables", EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, ELSEVIER SCIENCE PUBLISHERS B.V., AMSTERDAM, NL, (20000901), vol. 50, no. 2, doi:10.1016/S0939-6411(00)00062-X, ISSN 0939-6411, pages 257 - 262, XP004257199 [X] 1,4-11,13,14 * figure 1 * [Y] 1,3-14

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents